Bayer Seeks to Block Pfizer's Bovine Drug With IP Suit

Law360, New York (January 30, 2012, 8:20 PM EST) -- Bayer HealthCare LLC asked an Illinois federal court on Monday to block fellow pharmaceutical giant Pfizer Inc. from marketing a newly approved bovine respiratory disease treatment that Bayer says infringes one of its patents.

The company is seeking an emergency temporary restraining order and a permanent injunction to protect its own single-dose bovine respiratory disease drug, Baytril, from looming competition from Pfizer's Advocin, a single-dose fluoroquinolone injection expected to hit the markets Feb. 13. The one-time dosing used by Advocin is protected by a Bayer patent,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.